
Comprehensive Immune and Mutational Profile of Melanoma
by OmniSeq Staff | Jan 25, 2018

CTLA-4 Overexpression Does Not Confer Response to Ipilimumab in Melanoma
by OmniSeq Staff | Jan 13, 2018
Follow Us on Twitter
This December, Dr. Sarabjot Pabla joins the speaker lineup for the TIGIT Axis Therapies Digital Summit. His presentation will focus on TIGIT RNA expressions and their impact in precision oncology medicines. Register for the virtual event today: https://bit.ly/3NAKg3S
LABCORP EXPANDS ACCESS TO COMPREHENSIVE GENOMIC TESTING THROUGH NEW LUNG CANCER PROGRAM UTILIZING OmniSeq INSIGHT
https://tinyurl.com/59xf82c6
@OmniSeq
@Labcorp
#oncology
#precisionmedicine